Linda Van Eldik, Sanders-Brown Center on Aging at the University of Kentucky (IMAGE)
Caption
Linda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the prevention of dementia, is ready for in-human testing.
Credit
UK Photo | Mark Cornelison
Usage Restrictions
None
License
Licensed content